移植后的骨病在接受脏移植的人群中:诊断和管理
Jia Wei Teh1, Conall Mac Gearailt2, David W P Lappin1,3
1Department of Nephrology, Galway University Hospital, H91 YR71 Galway, Ireland.
International journal of molecular sciences
|February 10, 2024
概括
移植后骨病 (PTBD) 在移植后很常见,导致骨折和增加健康风险. 这次审查涵盖了PTBD.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 整形外科 整形外科 整形外科
背景情况:
- 移植是衰竭的主要治疗方法.
- 移植后骨病 (PTBD) 很普遍,增加了关节骨折风险和死亡率.
- PTBD涉及先前存在的疾病和移植相关的因素,如免疫抑制.
研究的目的:
- 审查PTBD的病理生理学,风险评估,诊断和管理.
- 为了突出PTBD的复杂性,由于慢性病-矿物骨疾病和移植后的因素.
- 讨论PTBD诊断的挑战和可用的治疗策略.
主要方法:
- 对PTBD的病理生理学,危险因素和诊断方法的文献综述.
- 分析当前的非药物和药物治疗选择.
- 讨论诊断PTBD亚型的挑战.
主要成果:
- PTBD是多因素的,受持续性偏甲状腺功能障碍,性骨质疏松症,维生素D缺乏和FGF-23.3的影响.
- 风险评估需要确定一般性和脏特异性的因素.
- 由于骨活检的可用性有限,诊断具有挑战性.
结论:
- 有效管理PTBD需要采取全面的方法来解决其复杂的病理生理学.
- 早期风险评估和适当的诊断策略对于及时干预至关重要.
- 综合管理策略对于减轻骨折和改善移植接受者的结果至关重要.
相关概念视频
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


